Application

15290873 · METHODS OF ENHANCING ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY

Filed 2016-10-11 · Abandoned The official file ↗ · Art unit 1642 · Examiner Kauser M Akhoon Typical · CPC A61K 31/55 · VENTIRX PHARMACEUTICALS, INC. · COOLEY LLP

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

0.7 mo

to disposition 25.3 mo

Statutes raised

103

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.